Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07689851
What this trial is testing

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)UnknownNCT01228045
What this trial is testing

Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 30
Not applicableLooking for participantsNCT07178587
What this trial is testing

Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Gastro-Entero-Pancreatic Tumors (GEPs)
Nantes University Hospital 28
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Not applicableUnknownNCT04915807
What this trial is testing

Real-world Data (RWD) of Ramucirumab Plus Paclitaxel

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Hallym University Medical Center 222
Early research (Phase 1)Study completedNCT04805307
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Who this might be right for
Advanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer
Keymed Biosciences Co.Ltd 176
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableStudy completedNCT06477562
What this trial is testing

Surveillance Endoscopy After Proximal Gastriectomy With Double Tract Reconstruction.

Who this might be right for
Gastric CancerProximal Gastric Adenocarcinoma
Saint Vincent's Hospital, Korea 160
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableStudy completedNCT02415101
What this trial is testing

Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Cancer of the Esophagus
Karolinska University Hospital 202
Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Testing effectiveness (Phase 2)Looking for participantsNCT05927857
What this trial is testing

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Who this might be right for
Metastatic Gastric AdenocarcinomaSecond LineChemotherapy
National Health Research Institutes, Taiwan 45
Testing effectiveness (Phase 2)Study completedNCT00464893
What this trial is testing

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 70
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Testing effectiveness (Phase 2)UnknownNCT00178698
What this trial is testing

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Who this might be right for
Neuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more
The University of Texas Health Science Center, Houston 36
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Very early researchUnknownNCT05277987
What this trial is testing

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

Who this might be right for
CAR T-Cell Therapy
Shenzhen Fifth People's Hospital 18
Post-approval studies (Phase 4)Study completedNCT02426034
What this trial is testing

Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd. 2,004
Testing effectiveness (Phase 2)Looking for participantsNCT06121700
What this trial is testing

Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

Who this might be right for
AdenocarcinomaStomach NeoplasmGastroesophageal-junction Cancer+6 more
Fudan University 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06693128
What this trial is testing

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 80
Next Page